Dialytic therapy in acute renal failure: No reason for nihilism

Seminars in Dialysis

Volumn 9, Issue 3, 1996, Pages 230-234

  Himmelfarb, Jonathan ^a  

^a MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000600276     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139x.1996.tb00658.x     Document Type: Article

References (90)

1. Abel JJ, Rowntree LG, Turner BB: On removal of diffusible substances from circulating blood by means of dialysis. Trans Am Physicians 28:51, 1913
2. Abel JJ, Rowntree LG, Turner BB: On the removal of diffusible substances from the circulating blood of living animals by dialysis. J Pharmacol Exp Ther 5:275, 1913-1914
3. Kolff WJ, Berk HT, ter Welle M, et al.: The artificial kidney, a dialyzer with a great area. Acta Med Scand 117:121, 1994
4. Kolff WJ: First clinical experience with the artificial kidney. Ann Intern Med 62:608, 1965
5. McMurray SD, Luft FC, Maxwell DR, et al.: Prevailing patterns and predictor variables in patients with acute tubular necrosis. Arch Intern Med 138:950-955, 1978
6. Cioffi WG, Ashikaga T, Gamelli RL: Probability of surviving postoperative acute renal failure. Ann Surg 200:205-211, 1984
7. Lien J, Chan V: Risk factors influencing survival in acute renal failure treated by hemodialysis. Arch Intern Med 145:2067-2069, 1985
8. Wheeler DC, Feehally J, Walls J: High risk acute renal failure. Q J Med 61(234):977-984, 1986
9. Abreo K, Moorthy V, Osborn M: Changing patterns and outcome of acute renal failure requiring hemodialysis. Arch Intern Med 146:1338-1341, 1986
10. Lohr JW, McFarlane MJ, Grantham JJ: A clinical index to predict survival in acute renal failure patients requiring dialysis. Am J Kidney Dis XI:254-259, 1988
11. VanDerMerwe WM, Collins JF: Acute renal failure in a critical care unit. N Z Med J 102:96-98, 1989
12. Schaefer JH, Jochimsen F, Keller F, Wegscheider K, Distler A: Outcome prediction of acute renal failure in medical intensive care. Intensive Care Med 17:19-24, 1991
13. Spiegel DM, Ullian ME, Zerbe GO, Berl T: Determinants of survival and recovery in acute renal failure patients dialyzed in intensive-care units. Am J Nephrol 11:44-47, 1991
14. Chew SL, Lins RL, Daelemans R, DeBroe ME: Outcome in acute renal failure. Nephrol Dial Transplant 8:101-107, 1993
15. Frost L, Pedersen R, Bentzen S, Bille H, Hansen H: Short- and long-term outcome in a consecutive series of 419 patients with acute dialysis-requiring renal failure. Scand J Urol Nephrol 27:453-462, 1993
16. Spurney RF, Fulkerson WJ, Schwab SJ: Acute renal failure in critically ill patients: Prognosis for recovery of kidney function after prolonged dialysis support. Crit Care Med 19:8-11, 1991
17. Chertow GM, Christiansen CL, Cleary PD, Munro C, Lazarus JM: Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med 155:1505-1511, 1995
18. Barton IK, Hilton PJ, Taub NA, Warburton FG, Swan AV, Dwight J, Mason JC: Acute renal failure treated by haemofiltration: Factors affecting outcome. Q J Med 86:81-90, 1993
19. Turney JH, Marshall DH, Brownjohn AM, Ellis CM, Parsons FM: The evolution of acute renal failure, 1956-1988. Q J Med 74(273):83-104, 1990
20. Mujais SK, Ivanovich P, Vidovich MI: Dialysis in acute renal failure: Which membrane? Artif Organs 18(7):470-472, 1994
21. Mujais SK, Ivanovich P, Bereza LA, Vidovich MI: Dialysis in acute renal failure - Muddying the waters. ASAIO J 41(2):137-139, Apr-June 1995
22. Kaplow L, Goffinet J: Profound neutropenia during the early phase of hemodialysis. JAMA 203:133-135, 1968
23. Cheung AK: Biocompatibility of hemodialysis membranes. J Am Soc Nephrol 1:150-161, 1990
24. Hakim RM: Editorial Review: Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 44:484-494, 1993
25. Lazarus JM, Owen WF: Role of biocompatibility in dialysis morbidity and mortality. J Am Soc Nephrol 24:1019-1032, 1994
26. Horl WH, Stepinski J, Schafer RM, Wanner C, Heidland A: Role of proteases in hypercatabolic patients with renal failure. Kidney Int 24(Suppl. 16):S37-S42, 1983
27. Horl WH, Heidland A: Evidence for the participation of granulocyte proteinases on intradialytic catabolism. Clin Nephrol 21(6):314-322, 1984
28. Lim VS, Flanigan MJ: The effect of interdialytic interval on protein metabolism: Evidence suggesting dialysis-induced catabolism. Am J Kidney Dis XIV(2):96-100, 1989
29. Gutierrez A, Alvestrand A, Wahren J, Bergstrom J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 38:487-494, 1990
30. Jahn B, Betz M, Deppisch R, Janssen O, Hansch GM, Ritz E: Stimulation of beta 2-microglobulin synthesis in lymphocytes after exposure to Cuprophan dialyzer membranes. Kidney Int 40:285-290, 1991
31. Koch KM: Dialysis-related amyloidosis. Kidney Int 41:1416-1429, 1992
32. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992
33. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771-778, 1993
34. Beal AL, Cerra FB: Multiple organ failure syndrome in the 1990s. JAMA 271:226-233, 1994
35. Schulman G, Fogo A, Gung A, Badr K, Hakim R: Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 40:1069-1074, 1991
36. Linas SL, Whittenburg D, Parsons PE, Repine JE: Mild renal ischemia activates primed neutrophils to cause acute renal failure. Kidney Int 42:610-616, 1992
37. Schiffl H, Lang SM, Konig A, Strasser T, Haider MC, Held E: Biocompatible membranes in acute renal failure: Prospective case-controlled study. Lancet 344:570-572, 1994
38. Hakim RM, Wingard RL, Parker RA: Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 331:1338-1342, 1994
39. Kurtal H, von Herrath D, Schaefer K: Is the choice of membrane important for patients with acute renal failure requiring hemodialysis? Artif Organs 19:391-394, 1995
40. Hakim RM, Tolkiff-Rubin N, Himmelfarb JH, Wingard RL, Parker RA: A multicenter comparison of bioincompatible and biocompatible membranes in the treatment of acute renal failure. J Am Soc Nephrol 5:394, 1994
41. Kaplan AA, Paganini EP, Bosch JP: Effect of the dialysis membrane in acute renal failure. N Engl J Med 332:961, 1995
42. Kleinknecht D, Jungers P, Chanard J, Barbanel C, Ganeval D: Uremic and non-uremic complications in acute renal failure: Evaluation of early and frequent dialysis on prognosis. Kidney Int 1:190-196, 1972
43. Conger JD: A controlled evaluation of prophylactic dialysis in post-traumatic acute renal failure. The J Trauma 15:1056-1063, 1975
44. Gillum DM, Dixon BS, Yanover MJ, Kelleher SP, Shapiro MD, Benedetti RG, Dillingham MA, Paller MS, Goldberg JP, Tomford RC, Gordon JA, Conger JD: The role of intensive dialysis in acute renal failure. Clin Nephrol 25:249-255, 1986
45. Himmelfarb J, Hakim RM: Biocompatibility and risk of infection in haemodialysis patients. Nephrol Dial Transplant 9(Suppl 2):138-144, 1994
46. Conger JD: Does hemodialysis delay recovery from acute renal failure? Seminars in Dialysis 3:146-148, 1990
47. Adams PL, Adams FF, Bell PD, Navar LG: Impaired renal blood flow autoregulation in ischemic acute renal failure. Kidney International 18:68-76, 1980
48. Conger JD, Robinette JB, Hammond WS: Differences in vascular reactivity in models of ischemic acute renal failure. Kidney Int 39: 1087-1097, 1991
49. Storck M, Hartl WH, Zimmerer E, Inthorn D: Comparison of pump-driven and spontaneous continuous haemofiltration in post-operative acute renal failure. Lancet 337:452-455, 1991
50. Tapolyai M, Fedak S, Chaff C, Paganini EP: Delivered dialysis dose may influence acute renal failure outcome in ICU patients. J Am Soc Nephrol 5:530, 1994
51. Delmez JA, Windus DW, The St. Louis Nephrology Study Group: Hemodialysis prescription and delivery in a metropolitan community. Kidney Int 41:1023-1028, 1994
52. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription on patient morbidity. N Engl J Med 305:1176-1181, 1981
53. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329:1001-1006, 1993
54. Hakim RM, Breyer J, Ismail N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 23(5):661-669, 1994
55. Himmelfarb J, Holbrook D, McMonagle E, Robinson R, Nye L, Spratt D: Kt/V, nutritional parameters, serum cortisol, and insulin growth factor-1 levels and patient outcome in hemodialysis. Am J Kidney Dis 24(3):473-479, 1994
56. Parker TF, Husni L, Huang W, Lew N, Lowrie EG, Dallas Nephrology Associates: Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis 23(5):670-680, 1994
57. Collins AJ, Ma JZ, Umen A, Keshaviah P: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 23(2): 272-282, 1994
58. Chima CS, Meyer L, Hummell AC, Bosworth C, Heyka R, Paganini EP, Werynski A: Protein catabolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parental nutrition. J Am Soc Nephrol 3:1516-1521, 1993
59. Clark WR, Mueller BA, Alaka KJ, Macias WL: A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol 4:1413-1420, 1994
60. Feinstein EI, Blumenkrantz MJ, Healy M, Koffler A, Silberman H, Massry SG, Kopple JD: Clinical and metabolic responses to parenteral nutrition in acute renal failure. Medicine 60(2):124-137, 1981
61. Feinstein EI: Total parenteral nutritional support of patients with acute renal failure. Nutrition in Clinical Practice 3:9-13, 1988
62. Abel RM, Beck CH, Abbott WM, Ryan JA, Barnett GO, Fischer JE: Improved survival from acute renal failure after treatment with intravenous essential L-amino acids and glucose. N Engl J Med 288:695-699, 1973
63. Baek SM, Makabali GG, Bryan-Brown CW, et al: The influence of parenteral nutrition on the course of acute renal failure. Surgery, Gynecology & Obstetrics 141:405-408, 1975
64. Leonard CD, Luke RG, Seigel RR: Parenteral essential amino acids in acute renal failure. Urology VI(2):154-157, 1975
65. Bartlett RH, Mault JR, Dechert RE, Palmer J, Swartz RD, Port FK: Continuous arteriovenous hemofiltration: Improved survival in surgical acute renal failure? Surgery 100:400-408, 1986
66. Moore EE, Jones TN: Benefits of immediate jejunostomy feeding after major abdominal trauma - a prospective, randomized study. J Trauma 26(10):874-881, 1986
67. Moore FA, Moore EE, Jones TN, McCroskey BL, Peterson VM: TEN versus TPN following major abdominal trauma - reduced septic morbidity. J Trauma 29(7):916-923, 1989
68. Moore FA, Feliciano DW, Andrassy RJ, McArdle AH, Booth FV, Morgenstein-Wagner TB, Kellum JM, Welling RE, Moore EE: Early enteral feeding, compared with parenteral, reduces postoperative septic complications. Ann Surg 216(2):172-183, 1992
69. Kudsk KA, Croce MA, Fabian TC, Minard G, Tolley EA, Poret HA, Kuhl MR, Brown RO: Enterai versus parenteral feeding. Ann Surg 215(5):503-513, 1992
70. The Veteran Affairs Total Parenteral Nutrition Cooperative Study Group: Perioperative total parenteral nutrition in surgical patients. N Engl J Med 325:525-532, 1991
71. Alverdy JC, Aoys E, Moss GS: Total parenteral nutrition promotes bacterial translocation from the gut. Surgery 104:185-190, 1988
72. Meakins JL, Marshall W: The gastrointestinal tract: The "motor" of MOF. Arch Surg 121:197-201, 1986
73. Alverdy J: The importance of the mucosal system. Nutrition in Clinical Practice 7:99, 1992
74. Langkamp-Henken B, Glezer JA, Kudsk K: Immunologic structure and function of the gastrointestinal tract. Nutrition in Clinical Practice 7:100-108, 1992
75. Mehls O, Ritz E, Hunziker EB, Eggli P, Henrich U, Zapf J: Improvement of growth and food utilization by human recombinant growth hormone. Kidney Int 33:45-52, 1988
76. Zeigler TR, Lazarus JM, Young LS, Hakim RM, Wilmore DW: Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis. J Am Soc Nephrol 2:1130-1135, 1991
77. Schulman G, Wingard R, Hutchison RL, Lawrence P, Hakim RM: The effects of recombinant human growth hormone and intradialytic parenteral nutrition in malnourished hemodialysis patients. Am J Kidney Dis 21:527-534, 1993
78. Miller SB, Martin DR, Kissane J, Hammerman MR: Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat. Proc Natl Acad Sci USA 89:11876-11880, 1992
79. Schneider NS, Geronemus RP: Continuous arteriovenous hemodialysis. Kidney Int 33(Suppl 24):S159-S162, 1988
80. Macias WL, Mueller BA, Scarim SK, Robinson M, Rudy DW: Continuous venovenous hemofiltration: An alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure. Am J Kidney Dis XVII(4):451-458, 1991
81. Mehta RL: Renal replacement therapy for acute renal failure: Matching the method to the patient. Seminars in Dialysis 6(4):253-259, 1993
82. Paganini EP: Continuous renal replacement is the preferred treatment for all acute renal failure patients receiving intensive care. Seminars in Dialysis 6(3):176-179, 1993
83. Henrich WL: Are continuous therapies superior to standard hemodialysis in patients with acute renal failure? Arteriovenous or venovenous continuous therapies are not superior to standard hemodialysis in all patients with acute renal failure. Seminars in Dialysis 6(3): 174-176, 1993
84. Sigler MH, Manns M: Continuous renal replacement therapy in the critically ill patient with acute renal failure. Pros and cons. ASAIO Journal 1994, pp. 928-930
85. Kaplan AA: Continuous renal replacement therapies. Whom, how, and why. ASAIO Journal 1994, pp. 940-942
86. van Bommel EFH, Leunissen KML, Weimar W: Continuous renal replacement therapy for critically ill patients: An update. J of Intensive Care Med 9:265-280, 1994
87. Davenport A, Will EJ, Davidson AM: Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 21:328-338
88. Bellomo R, Tipping P, Boyce N: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 21:522-526, 1993
89. Bonnardeaux A, Pichette V, Ouimet D, Geadah D, Habel F, Cardinal J: Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis. Am J Kidney Dis XIX(1):31-38, 1992
90. Knaus WA, Wagner DP, Lynn J: Short-term mortality predictions for critically ill hospitalized adults: Science and ethics. Science 254:389-394, 1991